BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 29749862)

  • 21. The contribution of genetic variations of aryl hydrocarbon receptor pathway genes to male factor infertility.
    Merisalu A; Punab M; Altmäe S; Haller K; Tiido T; Peters M; Salumets A
    Fertil Steril; 2007 Oct; 88(4):854-9. PubMed ID: 17559847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymorphisms of human Ah receptor gene are not involved in lung cancer.
    Kawajiri K; Watanabe J; Eguchi H; Nakachi K; Kiyohara C; Hayashi S
    Pharmacogenetics; 1995 Jun; 5(3):151-8. PubMed ID: 7550366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid detection of single nucleotide polymorphisms related with lung cancer susceptibility of Chinese population.
    Liang G; Pu Y; Yin L
    Cancer Lett; 2005 Jun; 223(2):265-74. PubMed ID: 15896461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. WNT antagonist, DKK2, is a Notch signaling target in intestinal stem cells: augmentation of a negative regulation system for canonical WNT signaling pathway by the Notch-DKK2 signaling loop in primates.
    Katoh M; Katoh M
    Int J Mol Med; 2007 Jan; 19(1):197-201. PubMed ID: 17143565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association between polymorphisms in Wnt antagonist genes and bone response to hormone therapy in postmenopausal Korean women.
    Kim H; Lee DO; Ku SY; Kim SH; Kim JH; Kim JG
    Menopause; 2012 Sep; 19(9):1008-14. PubMed ID: 22668815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genotype and haplotype analysis of WNT genes in non-syndromic cleft lip with or without cleft palate.
    Mostowska A; Hozyasz KK; Biedziak B; Wojcicki P; Lianeri M; Jagodzinski PP
    Eur J Oral Sci; 2012 Feb; 120(1):1-8. PubMed ID: 22288914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population-based case-control study of AhR (aryl hydrocarbon receptor) and CYP1A2 polymorphisms and breast cancer risk.
    Long JR; Egan KM; Dunning L; Shu XO; Cai Q; Cai H; Dai Q; Holtzman J; Gao YT; Zheng W
    Pharmacogenet Genomics; 2006 Apr; 16(4):237-43. PubMed ID: 16538170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer.
    Zhang X; Miao X; Guo Y; Tan W; Zhou Y; Sun T; Wang Y; Lin D
    Hum Mutat; 2006 Jan; 27(1):110-7. PubMed ID: 16287156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction between organochlorines and the AHR gene, and risk of non-Hodgkin lymphoma.
    Ng CH; Janoo-Gilani R; Sipahimalani P; Gallagher RP; Gascoyne RD; Connors JM; Weber JP; Lai AS; Leach S; Le ND; Brooks-Wilson AR; Spinelli JJ
    Cancer Causes Control; 2010 Jan; 21(1):11-22. PubMed ID: 19821039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positional pathway screen of wnt signaling genes in schizophrenia: association with DKK4.
    Proitsi P; Li T; Hamilton G; Di Forti M; Collier D; Killick R; Chen R; Sham P; Murray R; Powell J; Lovestone S
    Biol Psychiatry; 2008 Jan; 63(1):13-6. PubMed ID: 17553464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between CYP1B1 polymorphisms (c.142C > G, c.355G > T, c.1294C > G) and lung cancer risk in Polish smokers.
    Sawrycki P; Domagalski K; Cechowska M; Gąsior M; Jarkiewicz-Tretyn J; Tretyn A
    Future Oncol; 2018 Jul; 14(16):1569-1577. PubMed ID: 29938532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cyclooxygenase 2 genetic variant interacting with tobacco smoking and the risk of lung cancer].
    Zhang Z; Liu R; Yang ZH; Wang GX; Shao SS; Song QQ; Zhang XM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Aug; 47(8):736-40. PubMed ID: 24246081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aryl hydrocarbon receptor gene transitions (c.-742C>T; c.1661G>A) and idiopathic male infertility: a case-control study with in silico and meta-analysis.
    Aftabi Y; Hosseinzadeh Colagar A; Mehrnejad F; Seyedrezazadeh E; Moudi E
    Environ Sci Pollut Res Int; 2017 Sep; 24(25):20599-20615. PubMed ID: 28712079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Xeroderma pigmentosum complementation group D polymorphism toward lung cancer susceptibility survival and response in patients treated with platinum chemotherapy.
    Lawania S; Singh N; Behera D; Sharma S
    Future Oncol; 2017 Dec; 13(29):2645-2665. PubMed ID: 29035087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of an association between an aryl hydrocarbon receptor gene (AHR) polymorphism and risk of male infertility.
    Gu A; Ji G; Long Y; Zhou Y; Shi X; Song L; Wang X
    Toxicol Sci; 2011 Aug; 122(2):415-21. PubMed ID: 21613234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AhR expression and polymorphisms are associated with risk of coronary arterial disease in Chinese population.
    Huang S; Shui X; He Y; Xue Y; Li J; Li G; Lei W; Chen C
    Sci Rep; 2015 Jan; 5():8022. PubMed ID: 25620626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic variations in the Wnt signaling pathway affect lung function in asthma patients.
    Wang SH; Xu F; Dang HX; Yang L
    Genet Mol Res; 2013 Jun; 12(2):1829-33. PubMed ID: 23315860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contributions of aryl hydrocarbon receptor genetic variants to the risk of glioma and PAH-DNA adducts.
    Gu A; Ji G; Jiang T; Lu A; You Y; Liu N; Luo C; Yan W; Zhao P
    Toxicol Sci; 2012 Aug; 128(2):357-64. PubMed ID: 22539616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene-gene interactions of the Wnt/β-catenin signaling pathway in knee osteoarthritis.
    Fernández-Torres J; Zamudio-Cuevas Y; López-Reyes A; Garrido-Rodríguez D; Martínez-Flores K; Lozada CA; Muñóz-Valle JF; Oregon-Romero E; Martínez-Nava GA
    Mol Biol Rep; 2018 Oct; 45(5):1089-1098. PubMed ID: 30083988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure and polymorphisms of human aryl hydrocarbon receptor repressor (AhRR) gene in a French population: relationship with CYP1A1 inducibility and lung cancer.
    Cauchi S; Stücker I; Cénée S; Kremers P; Beaune P; Massaad-Massade L
    Pharmacogenetics; 2003 Jun; 13(6):339-47. PubMed ID: 12777964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.